Ga offline met de app Player FM !
FDA approves Amgen's T-cell engager for lung cancer, BioMarin announces layoffs, FDA delays Ascendis drug review [The good, the bad, the ugly]
Manage episode 419252800 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — FDA approves Amgen T-cell engager for small cell lung cancer
The bad — BioMarin announces 170 layoffs
The ugly — FDA delays review of Ascendis hypoparathyroidism drug
57 afleveringen
Manage episode 419252800 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — FDA approves Amgen T-cell engager for small cell lung cancer
The bad — BioMarin announces 170 layoffs
The ugly — FDA delays review of Ascendis hypoparathyroidism drug
57 afleveringen
Alle afleveringen
×Welkom op Player FM!
Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.